Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Human T-cell leukemia virus type 1 (HTLV-1) causes chronic infection leading to development of adult T-cell leukemia (ATL) and inflammatory diseases. Non-human primates infected with simian T-cell leukemia virus type 1 (STLV-1) are considered to constitute a suitable animal model for HTLV-1 research. However, the function of the regulatory and accessory genes of STLV-1 has not been analyzed in detail. In this study, STLV-1 in naturally infected Japanese macaques was analyzed. Results: We identified spliced transcripts of STLV-1 corresponding to HTLV-1 tax and HTLV-1 bZIP factor (HBZ). STLV-1 Tax activated the NFAT, AP-1 and NF-κB signaling pathways, whereas STLV-1 bZIP factor (SBZ) suppressed them. Conversely, SBZ enhanced TGF-β signaling and induced Foxp3 expression. Furthermore, STLV-1 Tax activated the canonical Wnt pathway while SBZ suppressed it. STLV-1 Tax enhanced the viral promoter activity while SBZ suppressed its activation. Then we addressed the clonal proliferation of STLV-1+ cells by massively sequencing the provirus integration sites. Some clones proliferated distinctively in monkeys with higher STLV-1 proviral loads. Notably, one of the monkeys surveyed in this study developed T-cell lymphoma in the brain; STLV-1 provirus was integrated in the lymphoma cell genome. When anti-CCR4 antibody, mogamulizumab, was administered into STLV-1-infected monkeys, the proviral load decreased dramatically within 2 weeks. We observed that some abundant clones recovered after discontinuation of mogamulizumab administration. Conclusions: STLV-1 Tax and SBZ have functions similar to those of their counterparts in HTLV-1. This study demonstrates that Japanese macaques naturally infected with STLV-1 resemble HTLV-1 carriers and are a suitable model for the investigation of persistent HTLV-1 infection and asymptomatic HTLV-1 carrier state. Using these animals, we verified that mogamulizumab, which is currently used as a drug for relapsed ATL, is also effective in reducing the proviral load in asymptomatic individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428 · cited 4×
“Phylogenetic analyses of HTLV-1 subtypes and Japanese macaque STLV-1 AY604926 AY496596 U03139 EU444085 AY374453 J02029 D13784 L76414 L46624 AF074966 L02534 Mf-5 M57592 AF384866 Central African Subtype B Pygmies Subtype D Cosmopolitan Subtype A African STLV-1 Melanesian Subtype C Asian STLV-1 Additional file 1 Suppleme…”
BackgroundInfluentialHuman T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829 · cited 2×
“Most HTLV-1 carriers remain asymptomatic through their lives and only a small fraction of them develop ATL, a leukemia of HTLV-1-infected CD4 T cells, after a long latent period [4].”
BackgroundSelf-citationYoshie, O., Fujisawa, R., Nakayama, T., Harasawa, H., Tago, H., Izawa, D., Hieshima, K., Tatsumi, Y., Matsushima, K., Hasegawa, H., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1505 · Cited by 326 · cited 1×
“ATL cells express high levels of CC chemokine receptor 4 (CCR4) [28].”
BackgroundHTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319 · cited 1×
“The analysis of HBZ transgenic mice further demonstrated an increase in Foxp3 T cells [23].”
BackgroundSelf-citationYamano, Y., Araya, N., Sato, T., Utsunomiya, A., Azakami, K., Hasegawa, D., Izumi, T., Fujita, H., Aratani, S., Yagishita, N., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006517 · Cited by 140 · cited 1×
“HTLV-1-infected cells of healthy carriers also express CCR4, which indicates that mogamulizumab likely reduces the proviral load in HTLV-1-infected asymptomatic individuals [30].”
BackgroundMochizuki, M., Yamaguchi, K., Takatsuki, K., Watanabe, T., Mori, S., & Tajima, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)90699-4 · Cited by 132
Cited by
Afonso, P. V., Cassar, O., & Gessain, A. (2019) · Retrovirology · doi:10.1186/s12977-019-0504-z · Cited by 90
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo
Furuta, R., Yasunaga, J.-I., Miura, M., Sugata, K., Saito, A., Akari, H., Ueno, T., Takenouchi, N., Fujisawa, J.-I., Koh, K.-R., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006722 · Cited by 83
Self-citationSTLV-1 as a model for studying HTLV-1 infection
Jégado, B., Kashanchi, F., Dutartre, H., & Mahieux, R. (2019) · Retrovirology · doi:10.1186/s12977-019-0503-0 · Cited by 27
In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions
Izaki, M., Yasunaga, J.-I., Nosaka, K., Sugata, K., Utsunomiya, H., Suehiro, Y., Shichijo, T., Yamada, A., Sugawara, Y., Hibi, T., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009271 · Cited by 15
“For analyses of clonality, the provirus integration site in human and the Japanese macaque genome were amplified by linker-mediated PCR as previously described with some modification using Miseq (Illumina)[22,46,49].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Miura, M., Yasunaga, J.-I., Tanabe, J., Sugata, K., Zhao, T., Ma, G., Miyazato, P., Ohshima, K., Kaneko, A., Watanabe, A., Saito, A., Akari, H., & Matsuoka, M.
- Venue
- Retrovirology
- Published
- 2013-10-24
- Volume
- 10
- Issue
- 1
- Pages
- 118-118
- ISSN
- 1742-4690 (ISSN-L)
- OpenAlex
- W2137041048
- Cited by
- 50
- References
- 6
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection. https://app.cochat.ai/papers/10.1186/1742-4690-10-118
- The paper
- Miura, M., Yasunaga, J.-I., Tanabe, J., Sugata, K., Zhao, T., Ma, G., Miyazato, P., Ohshima, K., Kaneko, A., Watanabe, A., Saito, A., Akari, H., & Matsuoka, M. (2013). Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection. Retrovirology. https://doi.org/10.1186/1742-4690-10-118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.